Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma

Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma

Suying Lu,1,2,* Chengtao Sun,3,* Huimou Chen,1,2,* Chao Zhang,1,4,* Wei Li,5 Liuhong Wu,1,2 Jia Zhu,1,2 Feifei Sun,1,2 Junting Huang,1,2 Juan Wang,1,2 Zijun Zhen,1,2 Ruiqing Cai,1,2 Xiaofei Sun,1,2 Yizhuo Zhang,1,2 Xing Zhang1,6 1State Key Laboratory of Oncology in South China, Collaborative Innovat...

Full description

Bibliographic Details
Main Authors: Lu S, Sun C, Chen H, Zhang C, Li W, Wu L, Zhu J, Sun F, Huang J, Wang J, Zhen Z, Cai R, Sun X, Zhang Y, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Cancer Management and Research
Subjects:
rhabdomyosarcoma
geo
tcga
cdk1
mad2l1
prognosis.
Online Access:https://www.dovepress.com/bioinformatics-analysis-and-validation-identify-cdk1-and-mad2l1-as-pro-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/bioinformatics-analysis-and-validation-identify-cdk1-and-mad2l1-as-pro-peer-reviewed-article-CMAR

Similar Items